FluoGuide has started enrolment in its US phase II trial of FG001 in high-grade glioma. It is the company’s first trial under its US IND, and a step on the road towards approval in the US. The news comes days after FluoGuide signed a collaboration agreement with microscope maker Leica Microsystems focused on the same indication.
Read the full article at biostock.se:
https://biostock.se/en/2026/10/fluoguide-enrols-first-patient-in-us-brain-cancer-trial/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/